|
⚲
|
| Keyboard |
| Actuate Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001652935 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001652935] | |
| 10-Q | [0001652935] | |
| 3 | [0001652935] | |
| 4 | [0001652935] | |
| 8-K | [0001652935] | |
| D | [0001652935] | |
| SC 13D | [0001652935] | |
| SC 13G | [0001652935] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Voss Capital LP | Actuate Therapeutics Inc | [2025-12-17] |
| BIOS Fund I LP | Actuate Therapeutics Inc | [2024-08-19] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Actuate Therapeutics Inc | |
| Fletcher Aaron GL | |
| Zabrowski Dan | |
| Thomson Todd S | |
| Sawhney Roger | |
| Ronneberg Amy L | |
| Keyes Jason A | |
| Huber Martin H Jr | |
| Lytle Paul J | |
| Schmitt Daniel M | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2026-02-13 | Option exercise | 272,055 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2026-02-13 | Tax withheld | 121,874 | $4.33 | 527,714 |
|
Actuate Therapeutics Inc ACTU
Restricted Stock Units · derivative
|
2026-02-13 | Option exercise | 272,055 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2026-01-05 | Sell | 280,000 | $5.80 | 1,624,000 |
|
Actuate Therapeutics Inc ACTU
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2025-06-27 | Buy | 71,428 | $7.00 | 499,996 |
|
Actuate Therapeutics Inc ACTU
Warrant (Right to Buy) · derivative
|
2025-06-27 | Buy | 71,428 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Employee Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 204,285 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Employee Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 51,046 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Employee Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 49,394 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Employee Stock Option (right to buy) · derivative
|
2025-04-01 | Grant | 41,899 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||